Neurodegeneration affects millions of people in the U.S. Both domestically and internationally, neurodegeneration is increasingly burdening healthcare systems as life expectancies are increasing and populations in many nations are aging. Fortunately, our understanding of the molecular mechanisms of several neurodegenerative diseases is improving. In this course, we will explore the current understanding of several neurodegenerative diseases, including Alzheimer’s Disease, ALS, and Parkinson’s Disease as well as a few rare diseases. We will also explore the molecular mechanisms of emerging therapeutics in these diseases including deep brain stimulation, small molecules, and biologics. We will consider both approved drugs and drugs in the clinical pipeline. All course content will be supported by primary literature. Class sessions will include mini-lectures, student discussions, and group work.

Units: 1

Max Enrollment: 12

Prerequisites: Two 200-level BISC/BIOC courses. At least one of these must be BISC 219/BIOC 219 or BISC 220/BIOC 220.

Instructor: Staff

Distribution Requirements: NPS - Natural and Physical Sciences

Typical Periods Offered: Fall

Semesters Offered this Academic Year: Not Offered

Notes: